Biosimilars can reduce costs in treating inflammatory bowel disease, but are they really as effective and safe? Raymond Cross, MD, related his experience in working with these therapies at the virtual...
The many different classes of medications available for treating inflammatory bowel disease give gastroenterologists more options than ever before—and also more challenges in determining how to balance...
The treatment of inflammatory bowel disease has changed dramatically since the introduction of biologics and small molecule therapeutics. But does that mean older therapies no longer have any role? David...
Researchers investigated whether neuromuscular electrical stimulation could help patients who have undergone total knee arthroplasty regain muscle and strength more quickly after surgery.
Many patients with chronic hepatitis B virus (HBV) are experiencing improved outcomes thanks to the advent of antiviral therapies. However, not all patients with chronic HBV have been considered candidates...
Researchers set out to determine whether inhibiting interleukin-13 could alleviate the most serious complication of eosinophilic esophagitis. A 16-week study yielded promising results on 4 key measures.
...
It is unclear whether body size is linked to clinical and hemodynamic characteristics in PAH. In turn, researchers evaluated the relationship between body mass index, exercise capacity, and hemodynamics...
Current guidelines do not provide definitive recommendations for the use of oral prostacyclin pathway agents among patients with pulmonary arterial hypertension. In turn, an expert panel developed consensus...
The guideline includes 6 recommendations that address significant COPD management issues, including how to treat patients with COPD who report having exercise intolerance or dyspnea.
